Its effects extend to hepatic improvement, with decreased liver fat content and fibrosis-related markers such as fibroblast growth factor 21 (FGF-21) and procollagen type III (Pro-C3), suggesting a potential to reverse steatosis and early fibrosis. The gene discussed is FGF21; the disease is steatosis.